The influence of Simvastatin and Korargin on the clinical course of coronary heart disease, body weight and distribution of adipose tissue in patients with type 2 diabetes mellitus.
Diabetes mellitus (DM) is one of the most influential risk factors for the development of cardiovascular diseases. Incidence of coronary heart diseases (CHD) and acute myocardial infarction in diabetic patients is much higher than in people without diabetes. Type 2 DM affects other risk factors of...
Main Author: | E. A. Pogrebniak |
---|---|
Format: | Article |
Language: | English |
Published: |
Zaporozhye State Medical University
2013-06-01
|
Series: | Zaporožskij Medicinskij Žurnal |
Subjects: | |
Online Access: | http://zmj.zsmu.edu.ua/article/view/13574/11933 |
Similar Items
-
The efficiency of dyslipidemia control in real clinical practice and the possibilities of its correction in patients with coronary heart disease and diabetes mellitus in the long -term use of simvastatin
by: F. Yu. Valikulova, et al.
Published: (2014-07-01) -
The efficiency of dyslipidemia control in real clinical practice and the possibilities of its correction in patients with coronary heart disease and diabetes mellitus in the long -term use of simvastatin
by: F. Yu. Valikulova, et al.
Published: (2014-07-01) -
Effects of simvastatin with or without fenofibrate on echocardiographic findings of patients with coronary artery disease and dyslipidemia: a brief report
by: Karbasi-Afshar R, et al.
Published: (2012-09-01) -
Cardioprotective potential of simvastatin in the hyperhomocysteinemic rat heart
by: Ankur Rohilla, et al.
Published: (2012-01-01) -
The efficacy and safety of Simvastatin in the treatment of lipid abnormalities in diabetes mellitus
by: Ogbera A Okeoghene, et al.
Published: (2013-01-01)